BCMA CAR-T
IIT2025048
Phase 2 mab active
Quick answer
BCMA CAR-T for Multiple Myeloma, Plasma Cell Leukemia is a Phase 2 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Multiple Myeloma, Plasma Cell Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- active